Screener
Zentalis Pharmaceuticals, Inc. ZNTL Q2 2026 earnings
Reported August 6, 2026 · After market close
EPS-$0.59Miss by $0.10
EPS estimate-$0.49
Next report
Nov 10, 2026 (in 2 months)EPS estimate-$0.61
Versus estimates
Diluted EPS
FAQ
- When did Zentalis Pharmaceuticals, Inc. report Q2 2026 earnings?
- Zentalis Pharmaceuticals, Inc. (ZNTL) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Zentalis Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?
- Zentalis Pharmaceuticals, Inc. reported eps of $-0.59 for Q2 2026.
- Did Zentalis Pharmaceuticals, Inc. beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.49 by $0.10.
- How did Zentalis Pharmaceuticals, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 59.5% from $-0.37.
- Where can I find Zentalis Pharmaceuticals, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001725160-26-000061) and the 10-Q periodic report (0001725160-26-000062) directly on SEC EDGAR. The filing index links above go to sec.gov.
